| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 08/17/2005 | EP1051500B1 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 08/17/2005 | EP1034262B1 Compositions and methods for genetic modification of plants |
| 08/17/2005 | EP1007702B1 Method for increasing the gene expression of saccharose synthase |
| 08/17/2005 | EP0975674B1 Immunotoxins, comprising an onc protein, directed against malignant cells |
| 08/17/2005 | EP0857790B1 Process for producing optically active amino compounds |
| 08/17/2005 | CN1656231A Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection |
| 08/17/2005 | CN1656229A Method for the production of sulphur-containing fine chemicals by fermentation |
| 08/17/2005 | CN1656226A Methods for the production of unsaturated fatty acids |
| 08/17/2005 | CN1656225A Novel carbonyl reductase, gene encoding it and process for producing optically active alcohols using the same |
| 08/17/2005 | CN1656224A Genes encoding acetolactate synthase |
| 08/17/2005 | CN1656222A Antisense iap nucleobase oligomers and uses thereof |
| 08/17/2005 | CN1656220A Selection marker gene |
| 08/17/2005 | CN1656219A Novel polyphosphate:amp phosphotransferase |
| 08/17/2005 | CN1656218A Hydantoin racemase |
| 08/17/2005 | CN1656217A Modified phytases |
| 08/17/2005 | CN1656205A Stabilization of granules |
| 08/17/2005 | CN1656123A Proteins and methods useful for assessing risk of cardiovascular disease |
| 08/17/2005 | CN1656109A Non nucleoside reverse transcriptase inhibitors |
| 08/17/2005 | CN1656068A Polypeptides and biosynthetic pathways |
| 08/17/2005 | CN1655669A Nucleic acid constructs and methods for producing altered seed oil compositions |
| 08/17/2005 | CN1654661A Construction and expression of recombinant human trypsinogen 2 expression vector, preparation and application of its monoclonal antibody |
| 08/17/2005 | CN1654659A Monocotyledon choline single oxygenase gene and protein coded thereby |
| 08/17/2005 | CN1654643A Auxiliary renaturation process for preparing recombinant reteplase |
| 08/17/2005 | CN1654642A High-activity cellulase and its preparation method |
| 08/17/2005 | CN1654641A Fungamyl-like alpha-amylase variants |
| 08/17/2005 | CN1654640A 超氧化物歧化酶组合物及其制备方法 Superoxide dismutase composition and its preparation method |
| 08/17/2005 | CN1654639A Recombinant asparaginase with function of preventing and curing diabetes mellitus |
| 08/17/2005 | CN1654473A 重组幽门螺杆菌过氧化氢酶 Recombinant H. pylori catalase |
| 08/17/2005 | CN1215175C Protein production process |
| 08/17/2005 | CN1215174C Fermentation synergist for fuel alcohol |
| 08/17/2005 | CN1215172C Preparation of alpha-1, 4-glucan lyase and nucleic acid encoding same |
| 08/17/2005 | CN1215170C Method of producing lipase by fermentation process |
| 08/17/2005 | CN1215169C Production method of corn superoxide dismutase multienzyme |
| 08/17/2005 | CN1215167C Helicobacter pylori live vaccine |
| 08/16/2005 | US6930227 makes it possible to modify the caffeine biosynthesis metabolism of caffeine producing plants, plant tissues, or plant cells, thereby efficiently producing caffeine metabolism based compounds or modifying the production of caffeine in the plants |
| 08/16/2005 | US6930226 Nucleotide sequences coding polypeptide for use in the adjustment of the starch concentration in plant |
| 08/16/2005 | US6930225 Adjusting concentration of cellulose synthase in plants; genetic engineering |
| 08/16/2005 | US6930224 by way of transfecting and/or regenerating plant material under specified culture conditions which prevent or reduce the rate of or delay the rise in pH of the culture medium |
| 08/16/2005 | US6930180 Mutant protein for use as tool in genetic engineering |
| 08/16/2005 | US6930173 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/16/2005 | US6930172 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/16/2005 | US6930097 Matrix metalloproteinase and tumor necrosis factor inhibitors |
| 08/16/2005 | US6930084 Treating arthritis with TNF receptor releasing enzyme |
| 08/16/2005 | US6929940 specific amino acid sequences; oxalic acid degradation enzymes |
| 08/16/2005 | US6929939 Protein variants that exhibit reduced allergenicity when compared to the parental proteins; cosmetics |
| 08/16/2005 | US6929938 25501, a human transferase family member and uses therefor |
| 08/16/2005 | US6929937 Human transferase proteins and polynucleotides encoding the same |
| 08/16/2005 | US6929935 Gluconobacter oxydans 2-ketoreductase enzyme and applications thereof |
| 08/16/2005 | US6929933 genes for riboflavin biosynthesis in yeast, the proteins encoded therewith and genetic engineering process for the preparation of riboflavin starting from GTP using these genes and gene products |
| 08/16/2005 | US6929928 Genes encoding carotenoid compounds |
| 08/16/2005 | US6929925 Assays for sensory modulators using a sensory cell specific G-protein beta subunit |
| 08/16/2005 | US6929912 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 08/16/2005 | US6929808 Isolating modulators of amyloid expression; obtain plant, extract proteins, incubate with chromatographic column, elute, recover preferential protein |
| 08/11/2005 | WO2005073398A1 Method of assaying capability of inhibiting fat level increase |
| 08/11/2005 | WO2005073382A1 A novel hansenula polymorpha gene coding for alpha 1,6-mannosyltransferase and process for the production of recombinant glycoproteins with hansenula polymorpha mutant strain deficient in the same |
| 08/11/2005 | WO2005073381A2 Method for overproducing a specific recombinant protein with p. cinnabarinus monokaryotic strains |
| 08/11/2005 | WO2005073370A1 Enzyme composite |
| 08/11/2005 | WO2005073369A1 Protein with activity of hydrolyzing amylopectin, starch, glycogen and amylose, gene encoding the same, cell expressing the same, and production method thereof |
| 08/11/2005 | WO2005073368A1 Protein with activity of hydrolyzing dextran, starch, mutan, inulin and levan, gene encoding the same, cell expressing the same, and production method thereof |
| 08/11/2005 | WO2005073367A1 Production and purification of recombinant arylsulfatase a |
| 08/11/2005 | WO2005073364A2 Advanced microorganism for producing 1,2-propanediol |
| 08/11/2005 | WO2005072272A2 Compositions and methods for generating short double-stranded rna using mutated rnase iii |
| 08/11/2005 | WO2005072262A2 Methods and compositions for evolving microbial hydrogen production |
| 08/11/2005 | WO2005072254A2 Modulation of sulfate permease for photosynthetic hydrogen production |
| 08/11/2005 | WO2005072086A2 Optimized bacterial host strains of methylomonas sp.16a |
| 08/11/2005 | WO2005072057A2 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
| 08/11/2005 | WO2005064341A3 Methods for the in vitro diagnosis and in vitro prognosis of demyelinating diseases, and for the development of drugs against demyelinating diseases |
| 08/11/2005 | WO2005059139A3 Methods for the preparation of lysine by fermentation of corynebacterium glutamicum |
| 08/11/2005 | WO2005047513A3 Glycin decarboxylase complex as a herbicidal target |
| 08/11/2005 | WO2005040389A3 Compositions with chitinase activity |
| 08/11/2005 | WO2005040368A3 Crystals of an aurora-a tpx2 complex, tpx2 binding site of aurora-a, aurora-a ligands and their use |
| 08/11/2005 | WO2005040344A3 Generation of stabilized proteins by combinatorial consensus mutagenesis |
| 08/11/2005 | WO2005038017A3 Prevention of incorporation of non-standard amino acids into protein |
| 08/11/2005 | WO2005033142A3 Anti-nik antibodies and uses thereof |
| 08/11/2005 | WO2005026392A3 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |
| 08/11/2005 | WO2004094463A3 Peptide inhibitors of autophosphorylation protein kinases |
| 08/11/2005 | WO2004083396A3 Methods for the identification of inhibitors of porphobilinogen deaminase, bifunctional purine biosynthetic protein, and a transcription factor as antibiotics |
| 08/11/2005 | WO2004070025A3 Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders |
| 08/11/2005 | WO2004063360A9 Improved method for the production of vitamin b12 |
| 08/11/2005 | WO2004044169A3 Crystalline form of fatty acid amine hydrolase (faah) |
| 08/11/2005 | WO2004043407A3 Methods and products for treating staphylococcal infections |
| 08/11/2005 | WO2004033636A3 Protein modification and maintenance molecules |
| 08/11/2005 | WO2004013283A3 Thioredoxin mutants and uses thereof |
| 08/11/2005 | WO2004012683A3 Novel druggable regions in set domain proteins and methods of using the same |
| 08/11/2005 | WO2003072733A3 Modified bace |
| 08/11/2005 | WO2003035858A3 Bacterial polypeptides involved in nucleic acid processing |
| 08/11/2005 | US20050177901 Expression vector comprising nucleotide sequences coding proteins associated with carbohydrate metabolism, degradation and biosynthesis for use in enhancement of nutrient quality of crop plants |
| 08/11/2005 | US20050177899 Non-transgenic herbicide resistant plants |
| 08/11/2005 | US20050177891 Novel plant glucosidase I and use thereof for producing recombinant proteins with modified glycosylation |
| 08/11/2005 | US20050177890 Transposon being functional in mammals |
| 08/11/2005 | US20050177888 Useful for selecting compounds that inhibit beta secretase for treatment of neurodegenerative diseases, such as Alzheimer's disease. |
| 08/11/2005 | US20050176946 Constitutive promoter from Arabidopsis |
| 08/11/2005 | US20050176944 Intracellular signaling polypeptide for identifying modulator for prevention and treatment cell proliferative, endocrine, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, developmental, and vesicle trafficking disorders |
| 08/11/2005 | US20050176935 Dna dependent protein kinase catalytic subunit phosphorylation sites and antibodies thereto |
| 08/11/2005 | US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors |
| 08/11/2005 | US20050176740 Synergistic for cancer characterized by ras oncogene overexpression; N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine |
| 08/11/2005 | US20050176671 Drug screening; competitive binding; antitumor agents, antiproliferative agents, as promoter providing neuronal cell growth, wound healing, and cerebral injury healing; receptor binding assay, gene expression |
| 08/11/2005 | US20050176670 Recombinant DNA for gene suppression |
| 08/11/2005 | US20050176662 Administering an agent that modulates the expression or activity of an Age-related macular degeneration (AMDP)-related or phagocytosis-related gene for delaying or reversing a retinal or choridal degenerative disease |
| 08/11/2005 | US20050176648 oligopeptide including enantiomers, stereoisomers and tautomers, used as hepatitis c protease enzyme inhibitors for prophylaxis or prevention of viral diseases |